Newswise — ARLINGTON, Va., March 7, 2019 — Co-sponsors of the 2019 Multidisciplinary Thoracic Cancers Symposium announced today the three abstracts that will be highlighted next week in the symposium press program. Researchers will present their findings in an online presscast on Tuesday, March 12, from 11:00 a.m. to 12:00 p.m. Eastern. Interested reporters can register to receive embargoed news from the symposium at www.astro.org/thoracicpress.

The briefing will feature the following studies:

  • “Improved Overall Survival with Local Consolidative Therapy in Oligometastatic Non-Small Cell Lung Cancer: Results from a Cohort of 194 Patients with Synchronous Disease,” presented by Dr. Erin Corsini, University of Texas MD Anderson Cancer Center (Abstract 1)
  • “The Impact of the Stage III Randomized Trial by Takahashi et al. on the Use of Prophylactic Cranial Irradiation (PCI) in Patients with Extensive-Stage Small-Cell Lung Cancer (ES-SCLC),” presented by Dr. Olsi Gjyshi, University of Texas MD Anderson Cancer Center (Abstract 3)
  • “The Impact of Structured, Prospective Exposure to the NCCN Guidelines when Making Treatment Decisions: Improved Metrics of Guideline-Concordant Care for Patients with Non-Small Cell Lung Cancer,” presented by Dr. Susan Wu, University of California, San Francisco (Abstract 5)

The 2019 Multidisciplinary Thoracic Cancers Symposium will take place March 14-16 at the Hilton San Diego Bayfront in San Diego, California. Researchers will present advances in surgery, radiation therapy, chemotherapy and novel targeted therapies for lung cancer and other thoracic malignancies. The meeting is co-sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO) and The Society of Thoracic Surgeons (STS).

Credentialed journalists from accredited news organizations are invited to attend and report on the symposium, or to cover it remotely. For questions about media opportunities at the symposium, contact ASTRO’s media relations team at press@astro.org or 703-286-1600. More information about the meeting is available at the symposium website.

ABOUT THE SYMPOSIUM                           

The 2019 Multidisciplinary Thoracic Cancers Symposium is a two-and-a-half-day meeting that convenes radiation and medical oncologists, thoracic surgeons and all members of the treatment team for a practical and comprehensive examination of current thoracic cancer care. Scientific, interactive and case-based educational sessions will cover the latest research on multidisciplinary therapies, clinical applications and new treatment strategies, supportive care and toxicity mitigation. The meeting is cosponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO) and The Society of Thoracic Surgeons (STS).

ABOUT ASTRO

The American Society for Radiation Oncology (ASTRO) is the world’s largest radiation oncology society, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. The Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology • Biology • Physics, Practical Radiation Oncology and Advances in Radiation Oncology; developed and maintains an extensive patient website, RT Answers; and created the nonprofit foundation Radiation Oncology Institute. To learn more about ASTRO, visit our website, sign up to receive our news and follow us on our blog, Facebook, Twitter and LinkedIn.

ABOUT ASCO

Founded in 1964, the American Society of Clinical Oncology (ASCO) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.

ABOUT STS

Founded in 1964, The Society of Thoracic Surgeons is a not-for-profit organization representing approximately 7,200 cardiothoracic surgeons, researchers, and allied health care professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus, as well as other surgical procedures within the chest. The Society’s mission is to enhance the ability of cardiothoracic surgeons to provide the highest quality patient care through education, research, and advocacy.